A fundamental question remaining for future studies is whether ASCL1 and other transcription factors involved in tumor formation are similarly required for maintenance of glioma growth in the brain, and how much these transcription factors may contribute to glioma recurrence, if any, following multimodal treatments. Here, ASCL1 is linked to glioma.